Clinical trial

A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

NCT06980142

Study summary

ClinicalTrials.gov

A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention CM512 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-06-20

PhasePHASE2

Conditions

Chronic Obstructive Pulmonary Diseaseverified · MONDO: chronic obstructive pulmonary disease

Interventions

CM512BIOLOGICAL

PlaceboDRUG

Sponsors & collaborators

Keymed Biosciences Co.Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06980142 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.